Literature DB >> 27214307

Lignans from the Australian Endemic Plant Austrobaileya scandens.

Trong D Tran1, Ngoc B Pham1, Ron Booth2, Paul I Forster2, Ronald J Quinn1.   

Abstract

The sole species of the vascular plant family Austrobaileyaceae, Austrobaileya scandens, is endemic to the tropical rainforest of northeastern Queensland, Australia. A single lead-like enhanced fraction of A. scandens showed potent inhibition against human prostate cancer PC3 cells. Chemical investigation of this plant resulted in the isolation of two new aryltetralin lignans, austrobailignans 8 and 9 (1 and 2), and the synthetic compound nicotlactone B (3), newly identified as a natural product together with nine known lignans (4-12). Their structures were established on the basis of spectroscopic analyses. Absolute configurations of the new compounds were determined by quantum chemical electronic circular dichroism (ECD) calculations employing time-dependent density functional theory. The ECD calculations were also used to assign the absolute configuration of marphenol K (4) and revise the absolute configuration of kadsurindutin C (20). Ten out of the 12 isolated compounds inhibited the growth of PC3 cells with IC50 values ranging from micromolar to nanomolar. Marphenol A (5) was found for the first time to induce apoptosis and arrest the S cell cycle phase of PC3 cells.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27214307     DOI: 10.1021/acs.jnatprod.5b00988

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  2 in total

1.  Asymmetric Chemoenzymatic Synthesis of (-)-Podophyllotoxin and Related Aryltetralin Lignans.

Authors:  Jian Li; Xiao Zhang; Hans Renata
Journal:  Angew Chem Int Ed Engl       Date:  2019-07-17       Impact factor: 15.336

2.  LC-MS guided isolation of three pairs of enantiomeric alkaloids from Macleaya cordata and their enantioseparations, antiproliferative activity, apoptosis-inducing property.

Authors:  Chunmei Sai; Dahong Li; Shengge Li; Tong Han; Yongzhi Guo; Zhanlin Li; Huiming Hua
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.